Quick Answer
TherapeuticsMD, Inc. reported Total Assets of $37.66 million for fiscal year 2025.
TherapeuticsMD, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $37.66M | -3.0% |
| 2024 | $38.82M | -10.4% |
| 2023 | $43.31M | -52.1% |
| 2022 | $90.46M | -46.6% |
| 2021 | $169.47M | -6.7% |
| 2020 | $181.61M | -31.7% |
| 2019 | $265.99M | +25.5% |
| 2018 | $211.98M | +48.0% |
| 2017 | $143.23M | +0.5% |
| 2016 | $142.47M | +93.2% |
| 2015 | $73.73M | +24.8% |
| 2014 | $59.08M | -4.7% |
| 2013 | $62.02M | +946.5% |
| 2012 | $5.93M | +311.9% |
| 2011 | $1.44M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $38.67M | -2.2% | +0.4% |
| June 30, 2025 | $38.50M | -4.0% | +0.7% |
| March 31, 2025 | $38.24M | -9.2% | -1.5% |
| December 31, 2024 | $38.82M | -10.4% | -1.8% |
| September 30, 2024 | $39.55M | -21.7% | -1.4% |
| June 30, 2024 | $40.13M | -25.3% | -4.7% |
| March 31, 2024 | $42.09M | -29.4% | -2.8% |
| December 31, 2023 | $43.31M | -52.1% | -14.2% |
- TherapeuticsMD, Inc. showed a decrease of -3.0% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, TherapeuticsMD, Inc.’s total assets has grown by 2517.3% (from $1.44 million to $37.66 million).
- The most recent figure is from TherapeuticsMD, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: